Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12

AUTHORS

Vernon J Lee, Jonathan Yap, Joshua K Tay, Ian Barr, Qiuhan Gao, Hanley J Ho, Boon Huan Tan, Paul M Kelly, Paul A Tambyah, Anne Kelso, Mark I Chen

ABSTRACT

BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. METHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms. RESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted. CONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks. More... »

PAGES

164

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2334-10-164

DOI

http://dx.doi.org/10.1186/1471-2334-10-164

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028454525

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20537158


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoprevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Outbreaks", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemagglutination Inhibition Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza A Virus, H1N1 Subtype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Military Personnel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nasopharynx", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oseltamivir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reverse Transcriptase Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Singapore", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Australian National University", 
          "id": "https://www.grid.ac/institutes/grid.1001.0", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore", 
            "Centre for Health Services Research, National University of Singapore, Medical Drive, 117597, Singapore, Singapore", 
            "Department of Epidemiology and Public Health, National University of Singapore, Medical Drive, 117597, Singapore, Singapore", 
            "National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Vernon J", 
        "id": "sg:person.0760054051.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760054051.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yap", 
        "givenName": "Jonathan", 
        "id": "sg:person.01124670776.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124670776.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tay", 
        "givenName": "Joshua K", 
        "id": "sg:person.01150570333.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150570333.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Victorian Infectious Diseases Reference Laboratory", 
          "id": "https://www.grid.ac/institutes/grid.433799.3", 
          "name": [
            "WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barr", 
        "givenName": "Ian", 
        "id": "sg:person.01302120514.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302120514.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gao", 
        "givenName": "Qiuhan", 
        "id": "sg:person.0616265467.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616265467.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ho", 
        "givenName": "Hanley J", 
        "id": "sg:person.01024306167.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024306167.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "DSO National Laboratories", 
          "id": "https://www.grid.ac/institutes/grid.410760.4", 
          "name": [
            "Detection and Diagnostics Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, Medical Drive, 117510, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Boon Huan", 
        "id": "sg:person.01272172631.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272172631.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Australian National University", 
          "id": "https://www.grid.ac/institutes/grid.1001.0", 
          "name": [
            "National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kelly", 
        "givenName": "Paul M", 
        "id": "sg:person.0672012164.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672012164.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Division of Infectious Diseases, National University of Singapore, Lower Kent Ridge Road, 119074, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tambyah", 
        "givenName": "Paul A", 
        "id": "sg:person.010711506654.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010711506654.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Victorian Infectious Diseases Reference Laboratory", 
          "id": "https://www.grid.ac/institutes/grid.433799.3", 
          "name": [
            "WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kelso", 
        "givenName": "Anne", 
        "id": "sg:person.0645000227.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645000227.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tan Tock Seng Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240988.f", 
          "name": [
            "Department of Clinical Epidemiology, Tan Tock Seng Hospital, Jalan Tan Tock Seng, 308433, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Mark I", 
        "id": "sg:person.0634357115.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634357115.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3201/eid1303.060309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005952153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/381128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006220379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)14854-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008859942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.2001.49204.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012005473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.6.748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012848872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199910283411802", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016534245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3201/eid0703.010320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024823460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2010.404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027739937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0906089", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030448983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/345722", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032715119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)62126-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039880362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0905498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042060084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2897", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2897", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077927377", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079644865", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12", 
    "datePublishedReg": "2010-12-01", 
    "description": "BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.\nMETHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms.\nRESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted.\nCONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2334-10-164", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009", 
    "pagination": "164", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "878cbfb13e7413abf070a05e9c30da11df8b3b3a209593d3dc41d8f0805ffa9b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20537158"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2334-10-164"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028454525"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2334-10-164", 
      "https://app.dimensions.ai/details/publication/pub.1028454525"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000550.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2334-10-164"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      64 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2334-10-164 schema:about N03db290b5f194e4e8e2d4b66fe0a7243
2 N11cca9bf629a4cffa2d00db402499402
3 N14deb1138e2b47778f1a70fdbe11433e
4 N1d4fffd57df54fe98f91578949f96da8
5 N23074990870743ff9962ac9664e96c0a
6 N3b46b8dbb7e24e68bbaa65a3865faf29
7 N3eb5efa41b4544c6996de629ea7597f8
8 N6453a7b3c87f46d1b803a279adc85133
9 N6546a76f9ba64073b0f60c98be680c6b
10 N6bd093c82432486283ed90775100cf68
11 N735de5f57f3e401bab77224824086e76
12 N771e6ff8528748d399795a352d362204
13 N7e45a14b28ee470dabb36f1a8f911951
14 N85be858daa574b1d92078c21f7d65f3f
15 Nb2ee03f3f1a24a49aa2dccfb554e9819
16 Nb3c49abda59f4f16b94ea5be5d044946
17 Ncc8f870ae3424f89827b7c335b64461b
18 Ndaa001d7d6ea476ea0f92124a29e05e6
19 Ne861e842f8d445d6a7c1ff2625d5e1b7
20 anzsrc-for:11
21 anzsrc-for:1117
22 schema:author N5fac62f17e0d44ad82fca1d6e25a43d9
23 schema:citation https://app.dimensions.ai/details/publication/pub.1077927377
24 https://app.dimensions.ai/details/publication/pub.1079644865
25 https://doi.org/10.1001/jama.2010.404
26 https://doi.org/10.1001/jama.285.6.748
27 https://doi.org/10.1016/s0140-6736(03)14854-4
28 https://doi.org/10.1016/s0140-6736(09)62126-7
29 https://doi.org/10.1046/j.1532-5415.2001.49204.x
30 https://doi.org/10.1056/nejm199910283411802
31 https://doi.org/10.1056/nejmoa0905498
32 https://doi.org/10.1056/nejmoa0906089
33 https://doi.org/10.1086/345722
34 https://doi.org/10.1086/381128
35 https://doi.org/10.1136/bmj.b2799
36 https://doi.org/10.1136/bmj.b2897
37 https://doi.org/10.3201/eid0703.010320
38 https://doi.org/10.3201/eid1303.060309
39 schema:datePublished 2010-12
40 schema:datePublishedReg 2010-12-01
41 schema:description BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. METHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms. RESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted. CONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N81111c8069be46988996c3e2beeb3b5c
46 Nda8bba6708324acabc51504ab723fb3b
47 sg:journal.1024946
48 schema:name Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
49 schema:pagination 164
50 schema:productId N0bd0b7b146f04ef19503c3647756870f
51 N267fe88b40884796ad8c59b301dfae72
52 N845239f7da10467a98a9068bf9fa308e
53 Nadd890a3823d402585d70761942373bd
54 Nd51546c7ef684895a3bd22e6e1a4555b
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028454525
56 https://doi.org/10.1186/1471-2334-10-164
57 schema:sdDatePublished 2019-04-11T01:14
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N8aa19eceecdc4650811e72773d42fe50
60 schema:url http://link.springer.com/10.1186%2F1471-2334-10-164
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N03db290b5f194e4e8e2d4b66fe0a7243 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Reverse Transcriptase Polymerase Chain Reaction
66 rdf:type schema:DefinedTerm
67 N0bd0b7b146f04ef19503c3647756870f schema:name nlm_unique_id
68 schema:value 100968551
69 rdf:type schema:PropertyValue
70 N11cca9bf629a4cffa2d00db402499402 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Hemagglutination Inhibition Tests
72 rdf:type schema:DefinedTerm
73 N14deb1138e2b47778f1a70fdbe11433e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Singapore
75 rdf:type schema:DefinedTerm
76 N1d4fffd57df54fe98f91578949f96da8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Military Personnel
78 rdf:type schema:DefinedTerm
79 N23074990870743ff9962ac9664e96c0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Young Adult
81 rdf:type schema:DefinedTerm
82 N267fe88b40884796ad8c59b301dfae72 schema:name dimensions_id
83 schema:value pub.1028454525
84 rdf:type schema:PropertyValue
85 N36c28058fb9241de8ebab983b8e945a0 rdf:first sg:person.01302120514.26
86 rdf:rest Nd9c12c302fa6407fa5e8cc3e66c8bd23
87 N3b46b8dbb7e24e68bbaa65a3865faf29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Cohort Studies
89 rdf:type schema:DefinedTerm
90 N3eb5efa41b4544c6996de629ea7597f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Influenza A Virus, H1N1 Subtype
92 rdf:type schema:DefinedTerm
93 N5fac62f17e0d44ad82fca1d6e25a43d9 rdf:first sg:person.0760054051.35
94 rdf:rest N688b057a325645b1bd722436e9fd4436
95 N6453a7b3c87f46d1b803a279adc85133 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Nasopharynx
97 rdf:type schema:DefinedTerm
98 N6546a76f9ba64073b0f60c98be680c6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Oseltamivir
100 rdf:type schema:DefinedTerm
101 N688b057a325645b1bd722436e9fd4436 rdf:first sg:person.01124670776.47
102 rdf:rest N9fe8a01e7c4f49cbafe1ac741c7f30cb
103 N6bd093c82432486283ed90775100cf68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Male
105 rdf:type schema:DefinedTerm
106 N735de5f57f3e401bab77224824086e76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name RNA, Viral
108 rdf:type schema:DefinedTerm
109 N74a8602cfe064b308ba86a73a00662ee rdf:first sg:person.0672012164.38
110 rdf:rest Nc0a10c7da9e147638bd4d52493ae2c12
111 N771e6ff8528748d399795a352d362204 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Humans
113 rdf:type schema:DefinedTerm
114 N7cbe1e622e0945b3976b4ec6f16c0884 rdf:first sg:person.01024306167.31
115 rdf:rest Nb3dc49cfacc8433694e12b9741f30a4a
116 N7e45a14b28ee470dabb36f1a8f911951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Influenza, Human
118 rdf:type schema:DefinedTerm
119 N81111c8069be46988996c3e2beeb3b5c schema:volumeNumber 10
120 rdf:type schema:PublicationVolume
121 N845239f7da10467a98a9068bf9fa308e schema:name doi
122 schema:value 10.1186/1471-2334-10-164
123 rdf:type schema:PropertyValue
124 N85be858daa574b1d92078c21f7d65f3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Disease Outbreaks
126 rdf:type schema:DefinedTerm
127 N8aa19eceecdc4650811e72773d42fe50 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 N99029ac70b71402db5b061137aef4047 rdf:first sg:person.0634357115.84
130 rdf:rest rdf:nil
131 N9fe8a01e7c4f49cbafe1ac741c7f30cb rdf:first sg:person.01150570333.36
132 rdf:rest N36c28058fb9241de8ebab983b8e945a0
133 Nadd890a3823d402585d70761942373bd schema:name pubmed_id
134 schema:value 20537158
135 rdf:type schema:PropertyValue
136 Nb2ee03f3f1a24a49aa2dccfb554e9819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Adult
138 rdf:type schema:DefinedTerm
139 Nb3c49abda59f4f16b94ea5be5d044946 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Antiviral Agents
141 rdf:type schema:DefinedTerm
142 Nb3dc49cfacc8433694e12b9741f30a4a rdf:first sg:person.01272172631.41
143 rdf:rest N74a8602cfe064b308ba86a73a00662ee
144 Nc0a10c7da9e147638bd4d52493ae2c12 rdf:first sg:person.010711506654.18
145 rdf:rest Ndd38ed2d6bbc479288c062fcc7f20277
146 Ncc8f870ae3424f89827b7c335b64461b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Chemoprevention
148 rdf:type schema:DefinedTerm
149 Nd51546c7ef684895a3bd22e6e1a4555b schema:name readcube_id
150 schema:value 878cbfb13e7413abf070a05e9c30da11df8b3b3a209593d3dc41d8f0805ffa9b
151 rdf:type schema:PropertyValue
152 Nd9c12c302fa6407fa5e8cc3e66c8bd23 rdf:first sg:person.0616265467.10
153 rdf:rest N7cbe1e622e0945b3976b4ec6f16c0884
154 Nda8bba6708324acabc51504ab723fb3b schema:issueNumber 1
155 rdf:type schema:PublicationIssue
156 Ndaa001d7d6ea476ea0f92124a29e05e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Antibodies, Viral
158 rdf:type schema:DefinedTerm
159 Ndd38ed2d6bbc479288c062fcc7f20277 rdf:first sg:person.0645000227.41
160 rdf:rest N99029ac70b71402db5b061137aef4047
161 Ne861e842f8d445d6a7c1ff2625d5e1b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Surveys and Questionnaires
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
168 schema:name Public Health and Health Services
169 rdf:type schema:DefinedTerm
170 sg:journal.1024946 schema:issn 1471-2334
171 schema:name BMC Infectious Diseases
172 rdf:type schema:Periodical
173 sg:person.01024306167.31 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
174 schema:familyName Ho
175 schema:givenName Hanley J
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024306167.31
177 rdf:type schema:Person
178 sg:person.010711506654.18 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
179 schema:familyName Tambyah
180 schema:givenName Paul A
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010711506654.18
182 rdf:type schema:Person
183 sg:person.01124670776.47 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
184 schema:familyName Yap
185 schema:givenName Jonathan
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124670776.47
187 rdf:type schema:Person
188 sg:person.01150570333.36 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
189 schema:familyName Tay
190 schema:givenName Joshua K
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150570333.36
192 rdf:type schema:Person
193 sg:person.01272172631.41 schema:affiliation https://www.grid.ac/institutes/grid.410760.4
194 schema:familyName Tan
195 schema:givenName Boon Huan
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272172631.41
197 rdf:type schema:Person
198 sg:person.01302120514.26 schema:affiliation https://www.grid.ac/institutes/grid.433799.3
199 schema:familyName Barr
200 schema:givenName Ian
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302120514.26
202 rdf:type schema:Person
203 sg:person.0616265467.10 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
204 schema:familyName Gao
205 schema:givenName Qiuhan
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616265467.10
207 rdf:type schema:Person
208 sg:person.0634357115.84 schema:affiliation https://www.grid.ac/institutes/grid.240988.f
209 schema:familyName Chen
210 schema:givenName Mark I
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634357115.84
212 rdf:type schema:Person
213 sg:person.0645000227.41 schema:affiliation https://www.grid.ac/institutes/grid.433799.3
214 schema:familyName Kelso
215 schema:givenName Anne
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645000227.41
217 rdf:type schema:Person
218 sg:person.0672012164.38 schema:affiliation https://www.grid.ac/institutes/grid.1001.0
219 schema:familyName Kelly
220 schema:givenName Paul M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672012164.38
222 rdf:type schema:Person
223 sg:person.0760054051.35 schema:affiliation https://www.grid.ac/institutes/grid.1001.0
224 schema:familyName Lee
225 schema:givenName Vernon J
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760054051.35
227 rdf:type schema:Person
228 https://app.dimensions.ai/details/publication/pub.1077927377 schema:CreativeWork
229 https://app.dimensions.ai/details/publication/pub.1079644865 schema:CreativeWork
230 https://doi.org/10.1001/jama.2010.404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027739937
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1001/jama.285.6.748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012848872
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0140-6736(03)14854-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008859942
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0140-6736(09)62126-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039880362
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1046/j.1532-5415.2001.49204.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012005473
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejm199910283411802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016534245
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1056/nejmoa0905498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042060084
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1056/nejmoa0906089 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030448983
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1086/345722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032715119
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1086/381128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006220379
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1136/bmj.b2799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062802496
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1136/bmj.b2897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062802581
253 rdf:type schema:CreativeWork
254 https://doi.org/10.3201/eid0703.010320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024823460
255 rdf:type schema:CreativeWork
256 https://doi.org/10.3201/eid1303.060309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005952153
257 rdf:type schema:CreativeWork
258 https://www.grid.ac/institutes/grid.1001.0 schema:alternateName Australian National University
259 schema:name Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore
260 Centre for Health Services Research, National University of Singapore, Medical Drive, 117597, Singapore, Singapore
261 Department of Epidemiology and Public Health, National University of Singapore, Medical Drive, 117597, Singapore, Singapore
262 National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.240988.f schema:alternateName Tan Tock Seng Hospital
265 schema:name Department of Clinical Epidemiology, Tan Tock Seng Hospital, Jalan Tan Tock Seng, 308433, Singapore, Singapore
266 rdf:type schema:Organization
267 https://www.grid.ac/institutes/grid.410760.4 schema:alternateName DSO National Laboratories
268 schema:name Detection and Diagnostics Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, Medical Drive, 117510, Singapore, Singapore
269 rdf:type schema:Organization
270 https://www.grid.ac/institutes/grid.4280.e schema:alternateName National University of Singapore
271 schema:name Division of Infectious Diseases, National University of Singapore, Lower Kent Ridge Road, 119074, Singapore, Singapore
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.433799.3 schema:alternateName Victorian Infectious Diseases Reference Laboratory
274 schema:name WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.452314.5 schema:alternateName Ministry of Defence
277 schema:name Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...